Current management of left main coronary artery disease

Jean Fajadet, Alaide Chieffo

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Coronary artery bypass surgery is considered as the gold standard treatment of unprotected left main coronary artery (ULMCA) disease. Over the last 20 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions (PCIs) for the treatment of left main (LM) coronary artery lesion. The recent data comparing efficacy and safety of PCIs using drug-eluting stent and coronary artery bypass surgery showed comparable results in terms of safety and a lower need for repeat revascularization for coronary artery bypass surgery. Patient selection for both techniques is fundamental and directly impacts the clinical outcome. Further randomized trials must be conducted to precise the indications of both techniques of revascularization in the treatment of LM disease. Published on behalf of the European Society of Cardiology. All rights reserved.

Original languageEnglish
Pages (from-to)36-50
Number of pages15
JournalEuropean Heart Journal
Volume33
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Coronary Artery Bypass
Coronary Artery Disease
Percutaneous Coronary Intervention
Safety
Drug-Eluting Stents
Patient Selection
Stents
Coronary Vessels
Technology

Keywords

  • Bifurcation lesions
  • Coronary bypass grafting
  • Left main coronary artery disease
  • Percutaneous coronary interventions

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Current management of left main coronary artery disease. / Fajadet, Jean; Chieffo, Alaide.

In: European Heart Journal, Vol. 33, No. 1, 01.2012, p. 36-50.

Research output: Contribution to journalArticle

@article{230262610cc143798ba7593c5060f248,
title = "Current management of left main coronary artery disease",
abstract = "Coronary artery bypass surgery is considered as the gold standard treatment of unprotected left main coronary artery (ULMCA) disease. Over the last 20 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions (PCIs) for the treatment of left main (LM) coronary artery lesion. The recent data comparing efficacy and safety of PCIs using drug-eluting stent and coronary artery bypass surgery showed comparable results in terms of safety and a lower need for repeat revascularization for coronary artery bypass surgery. Patient selection for both techniques is fundamental and directly impacts the clinical outcome. Further randomized trials must be conducted to precise the indications of both techniques of revascularization in the treatment of LM disease. Published on behalf of the European Society of Cardiology. All rights reserved.",
keywords = "Bifurcation lesions, Coronary bypass grafting, Left main coronary artery disease, Percutaneous coronary interventions",
author = "Jean Fajadet and Alaide Chieffo",
year = "2012",
month = "1",
doi = "10.1093/eurheartj/ehr426",
language = "English",
volume = "33",
pages = "36--50",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Current management of left main coronary artery disease

AU - Fajadet, Jean

AU - Chieffo, Alaide

PY - 2012/1

Y1 - 2012/1

N2 - Coronary artery bypass surgery is considered as the gold standard treatment of unprotected left main coronary artery (ULMCA) disease. Over the last 20 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions (PCIs) for the treatment of left main (LM) coronary artery lesion. The recent data comparing efficacy and safety of PCIs using drug-eluting stent and coronary artery bypass surgery showed comparable results in terms of safety and a lower need for repeat revascularization for coronary artery bypass surgery. Patient selection for both techniques is fundamental and directly impacts the clinical outcome. Further randomized trials must be conducted to precise the indications of both techniques of revascularization in the treatment of LM disease. Published on behalf of the European Society of Cardiology. All rights reserved.

AB - Coronary artery bypass surgery is considered as the gold standard treatment of unprotected left main coronary artery (ULMCA) disease. Over the last 20 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions (PCIs) for the treatment of left main (LM) coronary artery lesion. The recent data comparing efficacy and safety of PCIs using drug-eluting stent and coronary artery bypass surgery showed comparable results in terms of safety and a lower need for repeat revascularization for coronary artery bypass surgery. Patient selection for both techniques is fundamental and directly impacts the clinical outcome. Further randomized trials must be conducted to precise the indications of both techniques of revascularization in the treatment of LM disease. Published on behalf of the European Society of Cardiology. All rights reserved.

KW - Bifurcation lesions

KW - Coronary bypass grafting

KW - Left main coronary artery disease

KW - Percutaneous coronary interventions

UR - http://www.scopus.com/inward/record.url?scp=84855514585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855514585&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehr426

DO - 10.1093/eurheartj/ehr426

M3 - Article

C2 - 22210689

AN - SCOPUS:84855514585

VL - 33

SP - 36

EP - 50

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 1

ER -